Peripheral Interventions Market Size & Share 2023 to 2032
Market Size by Product (Catheters, Sheath, Stents, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, IVC Filters), by Application (Peripheral Artery Disease, Venous Thromboembolism), by End Use, – Forecast.
Report ID: GMI2915
|
Published Date: September 2023
|
Report Format: PDF
Download Free PDF
Authors:
Mariam Faizullabhoy, Pratiksha Kamthe
Peripheral Interventions Market Size
Peripheral Interventions Market size reached USD 8.7 billion in 2022 and is set to expand significantly at more than 9% CAGR from 2023-2032, driven by the rising prevalence of peripheral artery diseases across the globe.
Peripheral Interventions Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The rising risks of developing peripheral artery disease (PAD) with age, combined with other factors, such as smoking cigarettes, sedentary lifestyle, diabetes, and obesity will drive the market growth. The American College of Cardiology reported in 2023 that PAD affects more than 12 million Americans and 200 million individuals globally. Several market players are developing innovative treatment techniques with massive investments in R&D activities to match the rising demand for more effective and less invasive treatment options for patients with complex PADs.
To cite an instance, in June 2023, Endologix received FDA approval for its Detour system to treat long, complex superficial femoropopliteal lesions. Moreover, the growing incidence of hypertension coupled with the high prevalence of cardiovascular diseases have surged the adoption of peripheral interventional devices, propelling the market progress.
The higher cost of therapy and diagnostics associated with peripheral therapies is one of the major restrictions to the peripheral interventions market expansion. According to the American Heart Association, a patient in Canada spends around USD 4,600 per year on treatment and diagnosis of peripheral atrial disease. Additionally, the significant expenses of establishing cath laboratories and the rising attempts to reduce costs may limit the market growth. To cite an instance, a few hospitals in India experienced significant declines in return on investment in cath laboratories due to hampered lab operations.
Covid-19 Impact
The COVID-19 pandemic posed challenges for peripheral intervention practices due to the reduction and suspension of screening programs and services in various nations while bringing significant influence on elective catheterization laboratory activities in hospitals for structural cardiac operations. For instance, the European Society of Cardiology advised postponing of all non-emergency treatments, including peripheral vascular interventions, leading to hampered market growth. However, the increased focus on telemedicine and remote monitoring influenced the adoption of minimally invasive peripheral intervention techniques, contributing to the industry development.
Peripheral Interventions Market Trends
Rising technological developments for providing enhanced care and improved treatment results coupled with the higher effectiveness of modern gadgets in non-invasive interventional treatments will provide potential growth opportunities for industry growth. The growing intervention by industry players on heavily investing in improving product innovations to further enhance procedure volumes for boosted product demand and expanded client base will also influence the industry growth. For instance, in February 2023, BIOTRONIK received FDA 510(k) clearance and the CE mark for its Oscar® multipurpose peripheral catheter designed for percutaneous transluminal procedures in the peripheral vascular.
Peripheral Interventions Market Analysis
Peripheral interventions market from the catheters segment is expected to exhibit 9.3% CAGR from 2023-2032. The growth is owing to the extensive usage of peripheral intravenous catheters (PIVC) for treatment procedures in hospitalized patients. Moreover, the growing emphasis by market participants on discovering and commercializing medical products to revolutionize the treatment of calcified cardiovascular disease is expected to fuel segment trends. For instance, in March 2023, Shockwave Medical, Inc., a leading developer of Intravascular Lithotripsy, received the FDA approval for the commercial launch of the Shockwave L6 Peripheral IVL Catheter.
Peripheral interventions market from the peripheral artery disease application segment is foreseen to depict considerable growth at 8.9% CAGR from 2023 to 2032. The growth is attributed to the increasing prevalence of peripheral artery disease (PAD) due to the rapidly aging population and lifestyle factors. Technological advancements in interventional devices and procedures, such as angioplasty and stenting, have led to enhanced treatment outcomes. In July 2023, according to a report by the FDA, stents and paclitaxel-coated balloons have demonstrated to improve blood flow to the legs and lessen the need for further treatments to unblock clogged blood arteries. Additionally, the rising awareness of the serious complications, including amputation caused by PADs is driving the demand for early diagnosis and intervention, contributing to the segment development.
North America peripheral interventions market is poised to amass more than USD 8.1 billion by 2032. The rising number of geriatric patients vulnerable to several cardiac disorders is expected to surge the demand for several advanced healthcare devices. According to the CDC, in 2021, around 695,000 Americans died from heart diseases. Moreover, the increasing acceptance of minimally invasive processes in the region is driving the adoption of peripheral interventional solutions. Furthermore, the rising focus of leading manufacturers on strategic efforts to expand their presence in America will augment the market outlook. For instance, in February 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc. (CSI), a U.S.-based medical device firm for offering new solutions for treating complicated artery conditions.
Peripheral Interventions Market Share
The competitive landscape of the peripheral interventions market includes: prominent companies such as
Peripheral Interventions Infustry News
Peripheral interventions market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Proudct (USD Million)
By Application (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →